(72 days)
No
The summary describes a pneumatic compression device that monitors blood flow and synchronizes compression. While it mentions detecting hemodynamic changes, there is no explicit mention of AI or ML algorithms being used for this detection or for optimizing the compression profile. The testing summary also does not indicate any studies related to AI/ML performance.
Yes
The device is intended to treat multiple medical conditions and symptoms, such as preventing DVT, diminishing post-operative pain and swelling, reducing wound healing time, enhancing blood circulation, and treating chronic venous insufficiency.
No
The "Device Description" section explicitly states, "The ActiveCare+DTx is not a diagnostic tool." While one system can detect hemodynamic changes, it is clarified that this detection does not constitute a diagnostic function.
No
The device description explicitly states it is a "portable, sequential, intermittent pneumatic compression device" that includes "rechargeable battery powered option" and "control units," indicating it is a hardware device with integrated software, not a software-only medical device.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The ActiveCare+S.F.T. and ActiveCare+DTx Systems are external compression devices that apply pressure to the lower limbs. They are used to physically enhance blood flow and prevent conditions like DVT.
- Lack of Sample Analysis: The device does not analyze any samples taken from the patient's body. It interacts with the body externally.
- Explicit Statement: The text explicitly states, "The ActiveCare+DTx is not a diagnostic tool." While this refers specifically to the detection of hemodynamic changes, the overall function of the device is therapeutic and preventative through physical means, not diagnostic through sample analysis.
Therefore, the ActiveCare+S.F.T. and ActiveCare+DTx Systems fall under the category of therapeutic medical devices, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are portable, ambulatory, sequential, intermittent pneumatic compression devices (IPCDs) prescribed by health care professionals. The systems include a rechargeable battery powered option allowing patient mobility and ease of use. These devices simulate muscle contractions in order to treat or enhance blood flow velocity in individuals experiencing venous impairment or reduced pulsatility (dysfunction of the muscle pump) when blood flow may become challenged or compromised, such as during and after major orthopedic surgery procedures e.g total joint (hip and knee) arthroplasty. They are intended for use in the clinical setting or home environment.
These devices are indicated for use in:
- Preventing Deep Vein Thrombosis (DVT)
- Diminishing post-operative pain and swelling
- Reducing wound healing time
- Patients at risk for deep vein thrombosis (DVT) and related pulmonary embolism (PE) (Venous Thromboembolism (VTE))
- Treatment of venous stasis
- Treatment and assistance in healing: Stasis dermatitis, venous stasis ulcers, arterial and diabetic leg ulcers
- Enhancing blood circulation
- Treatment of chronic venous insufficiency
- Reducing edema
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are intended to provide external compression in synchrony with the specific patient's natural venous blood flow return profile in order to achieve a high pulsatile venous blood flow.
In addition, the ActiveCare+DTx System can detect hemodynamic changes in venous blood flow.
Product codes
JOW
Device Description
The ActiveCare+DTx and ActiveCare+S.F.T. Systems are prescriptive, portable, sequential, intermittent pneumatic compression devices designed to apply sequential compression to the lower limb. The systems include a rechargeable battery powered option (in addition to an AC/DC adapter) allowing patient mobility and ease of use. The control units of the Systems provide the user with several treatment options: compression of the foot - single or double, compression of the calf – single or double, compression of the thigh – single or double, and combined compression of any combination of two sleeves. The foot compression program is an intermittent pressure pulse application to a single celled foot sleeve. The calf and thigh compression program is a sequential intermittent application of a pressure to a three-celled cuff sleeve.
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are intended to provide continuous monitoring of each patient's venous phasic blood flow on a real time basis so that the timing of external compression is in synchrony with the specific patient's natural venous blood flow return profile in order to achieve a high pulsatile venous blood flow.
In addition, the ActiveCare+DTx System can detect hemodynamic changes that may be indicative of the development of a venous blood flow obstruction event in the treated patient's limbs. The ActiveCare+DTx is not a diagnostic tool.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
lower limb
Indicated Patient Age Range
Not Found
Intended User / Care Setting
health care professionals. They are intended for use in the clinical setting or home environment.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Testing referenced in support of this submission includes: Electrical Safety, EMC, Usability, Software Validation, Risk Analysis, internal testing and published Clinical Literature. The data provided demonstrates that the modified ActiveCare+S.F.T. and ActiveCare+DTx Systems are substantially equivalent to its predicates, and raises no new safety or effectiveness issues.
Key Metrics
Not Found
Predicate Device(s)
K140755, K133274, K102737, K141609
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.5800 Compressible limb sleeve.
(a)
Identification. A compressible limb sleeve is a device that is used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb.(b)
Classification. Class II (performance standards).
0
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
December 4, 2014
Medical Compressions System (DBN) Ltd. Adely Levy RA & QA General Manager 12 Ha'ilan Street, PO Box 75 Or Akiva, Israel 30600
Re: K142728
Trade/Device Name: Activecare+SFT; Activecare+SFT Homecare; Activecare+DTx ; Activecare+DTx Homecare Regulation Number: 21 CFR 870.5800 Regulation Name: Compressible Limb Sleeve Regulatory Class: Class II Product Code: JOW Dated: September 19, 2014 Received: September 23, 2014
Dear Adely Levy,
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply
1
with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
M.A. Hilleman
for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use Statement
510(k) Number (if known):K142728
Device Name: ActiveCare+S.F.T. and ActiveCare+DTx Systems
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are portable, ambulatory, sequential. intermittent pneumatic compression devices (IPCDs) prescribed by health care professionals. The systems include a rechargeable battery powered option allowing patient mobility and ease of use. These devices simulate muscle contractions in order to treat or enhance blood flow velocity in individuals experiencing venous impairment or reduced pulsatility (dysfunction of the muscle pump) when blood flow may become challenged or compromised, such as during and after major orthopedic surgery procedures e.g total joint (hip and knee) arthroplasty. They are intended for use in the clinical setting or home environment.
These devices are indicated for use in:
- Preventing Deep Vein Thrombosis (DVT) ●
- Diminishing post-operative pain and swelling ●
- Reducing wound healing time ●
- Patients at risk for deep vein thrombosis (DVT) and related pulmonary embolism (PE) ● (Venous Thromboembolism (VTE))
- Treatment of venous stasis
- Treatment and assistance in healing: Stasis dermatitis, venous stasis ulcers, arterial and ● diabetic leg ulcers
- Enhancing blood circulation ●
- Treatment of chronic venous insufficiency
- Reducing edema
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are intended to provide external compression in synchrony with the specific patient's natural venous blood flow return profile in order to achieve a high pulsatile venous blood flow.
In addition, the ActiveCare+DTx System can detect hemodynamic changes in venous blood flow.
Prescription Use X________________ AND/OR Over-The-Counter Use (Per 21 C.F.R. 801 Subpart D) (Per 21 C.F.R. 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
3
510(K) SUMMARY: K142728
Medical Compression Systems (DBN) Ltd's ActiveCare+S.F.T and ActiveCare+DTx
Date Prepared: November 21, 2014
| Submitter and Manufacturer | Contact Person |
|---|---|
| Medical Compression Systems (DBN) Ltd. | Adely Levy |
| 12 Ha'ilan Street, PO Box 75 | 12 Ha'ilan Street, P.O. Box 75 |
| Or Akiva 30600, Israel | Or Akiva 30600, Israel |
| Tel:+972(4) 6266630 | Telephone:+972 (4) 6266630 |
| Fax: +972 (4) 6266640 | Fax: +972 (4) 6266640 |
| E-mail: adely@mcsmed.com | E-mail: adely@mcsmed.com |
| Manufacturer Registration Number: 9616558 |
Name of Device
| Trade Names: | ActiveCare+S.F.T. and ActiveCare+DTx Systems |
|---|---|
| Common Names: | Pneumatic Compression System |
| Classification Name: | Compressible Limb Sleeve |
Device Classification/FDA Reviewing Branch
The Division of Cardiovascular Devices has classified Compressible Limb Sleeves as Class II devices pursuant to 21 C.F.R. § 870.5800 (JOW).
Predicate Device Information
| Predicate Device Name | 510(k) | Manufacturer |
|---|---|---|
| ActiveCare+S.F.T. and | ||
| ActiveCare+DTx Systems | K140755 | Medical Compression Systems |
| VENAPRO | K133274 | Innovamed Health |
| Kendall SCD 700 Sequential | ||
| Compression Controller, | K102737 | Covidien |
| Pulstar Logix Pump | K141609 | AlbaHealth LLC |
4
Intended Use
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are portable, ambulatory, sequential, intermittent pneumatic compression devices (IPCDs) prescribed by health care professionals. The systems include a rechargeable battery powered option allowing patient mobility and ease of use. These devices simulate muscle contractions in order to treat or enhance blood flow velocity in individuals experiencing venous impairment or reduced pulsatility (dysfunction of the muscle pump) when blood flow may become challenged or compromised such as during and after major orthopedic surgery procedures e.g. total joint (hip and knee) arthroplasty. They are intended for use in the clinical setting or home environment.
These devices are indicated for use in:
- . Preventing Deep Vein Thrombosis (DVT)
- . Diminishing post-operative pain and swelling
- . Reducing wound healing time
- Patients at risk for deep vein thrombosis (DVT) and related pulmonary ● embolism (PE) (Venous Thromboembolism (VTE))
- . Treatment of venous stasis
- Treatment and assistance in healing: Stasis dermatitis, venous stasis ulcers, . arterial and diabetic leg ulcers
- . Enhancing blood circulation
- Treatment of chronic venous insufficiency ●
- Reducing edema .
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are intended to provide external compression in synchrony with the specific patient's natural venous blood flow return profile in order to achieve a high pulsatile venous blood flow.
In addition, the ActiveCare+DTx System can detect hemodynamic changes in venous blood flow.
Device Description/Technological Characteristics
The ActiveCare+DTx and ActiveCare+S.F.T. Systems are prescriptive, portable, sequential, intermittent pneumatic compression devices designed to apply sequential compression to the lower limb. The systems include a rechargeable battery powered option (in addition to an AC/DC adapter) allowing patient mobility and ease of use. The control units of the Systems provide the user with several treatment options: compression of the foot - single or double, compression of the calf – single or double, compression of the thigh – single or double, and combined compression of any combination of two sleeves. The foot compression program is an intermittent pressure pulse application to a single celled foot sleeve. The calf and thigh compression program is a sequential intermittent application of a pressure to a three-celled cuff sleeve.
5
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are intended to provide continuous monitoring of each patient's venous phasic blood flow on a real time basis so that the timing of external compression is in synchrony with the specific patient's natural venous blood flow return profile in order to achieve a high pulsatile venous blood flow.
In addition, the ActiveCare+DTx System can detect hemodynamic changes that may be indicative of the development of a venous blood flow obstruction event in the treated patient's limbs. The ActiveCare+DTx is not a diagnostic tool.
Performance Data
Testing referenced in support of this submission includes: Electrical Safety, EMC, Usability, Software Validation, Risk Analysis, internal testing and published Clinical Literature. The data provided demonstrates that the modified ActiveCare+S.F.T. and ActiveCare+DTx Systems are substantially equivalent to its predicates, and raises no new safety or effectiveness issues.
Substantial Equivalence
The ActiveCare+S.F.T. and ActiveCare+DTx Systems are substantially equivalent in intended use and technological characteristics to the predicate devices. There are no new questions of safety and efficacy.